Epilepsy in Neurodegenerative Diseases: Related Drugs and Molecular Pathways
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10316/105326 https://doi.org/10.3390/ph14101057 |
Resumo: | Epilepsy is a chronic disease of the central nervous system characterized by an electrical imbalance in neurons. It is the second most prevalent neurological disease, with 50 million people affected around the world, and 30% of all epilepsies do not respond to available treatments. Currently, the main hypothesis about the molecular processes that trigger epileptic seizures and promote the neurotoxic effects that lead to cell death focuses on the exacerbation of the glutamate pathway and the massive influx of Ca2+ into neurons by different factors. However, other mechanisms have been proposed, and most of them have also been described in other neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, Huntington's disease, or multiple sclerosis. Interestingly, and mainly because of these common molecular links and the lack of effective treatments for these diseases, some antiseizure drugs have been investigated to evaluate their therapeutic potential in these pathologies. Therefore, in this review, we thoroughly investigate the common molecular pathways between epilepsy and the major neurodegenerative diseases, examine the incidence of epilepsy in these populations, and explore the use of current and innovative antiseizure drugs in the treatment of refractory epilepsy and other neurodegenerative diseases. |
id |
RCAP_1bf8dcde7b41aa13fee873de7588576f |
---|---|
oai_identifier_str |
oai:estudogeral.uc.pt:10316/105326 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Epilepsy in Neurodegenerative Diseases: Related Drugs and Molecular Pathwaysepilepsyneurodegenerative diseasesAlzheimer’s diseaseParkinson’s diseaseHuntington’s diseasemultiple sclerosisEpilepsy is a chronic disease of the central nervous system characterized by an electrical imbalance in neurons. It is the second most prevalent neurological disease, with 50 million people affected around the world, and 30% of all epilepsies do not respond to available treatments. Currently, the main hypothesis about the molecular processes that trigger epileptic seizures and promote the neurotoxic effects that lead to cell death focuses on the exacerbation of the glutamate pathway and the massive influx of Ca2+ into neurons by different factors. However, other mechanisms have been proposed, and most of them have also been described in other neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, Huntington's disease, or multiple sclerosis. Interestingly, and mainly because of these common molecular links and the lack of effective treatments for these diseases, some antiseizure drugs have been investigated to evaluate their therapeutic potential in these pathologies. Therefore, in this review, we thoroughly investigate the common molecular pathways between epilepsy and the major neurodegenerative diseases, examine the incidence of epilepsy in these populations, and explore the use of current and innovative antiseizure drugs in the treatment of refractory epilepsy and other neurodegenerative diseases.MDPI2021-10-18info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://hdl.handle.net/10316/105326http://hdl.handle.net/10316/105326https://doi.org/10.3390/ph14101057eng1424-8247Cano, AmandaFonseca, ElenaEttcheto, MirenSánchez-López, Elenade Rojas, ItziarAlonso-Lana, SilviaMorató, XavierSouto, Eliana B.Toledo, ManuelBoada, MercèMarquié, MartaRuíz, Agustíninfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-02-17T09:36:59Zoai:estudogeral.uc.pt:10316/105326Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T21:21:55.237595Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Epilepsy in Neurodegenerative Diseases: Related Drugs and Molecular Pathways |
title |
Epilepsy in Neurodegenerative Diseases: Related Drugs and Molecular Pathways |
spellingShingle |
Epilepsy in Neurodegenerative Diseases: Related Drugs and Molecular Pathways Cano, Amanda epilepsy neurodegenerative diseases Alzheimer’s disease Parkinson’s disease Huntington’s disease multiple sclerosis |
title_short |
Epilepsy in Neurodegenerative Diseases: Related Drugs and Molecular Pathways |
title_full |
Epilepsy in Neurodegenerative Diseases: Related Drugs and Molecular Pathways |
title_fullStr |
Epilepsy in Neurodegenerative Diseases: Related Drugs and Molecular Pathways |
title_full_unstemmed |
Epilepsy in Neurodegenerative Diseases: Related Drugs and Molecular Pathways |
title_sort |
Epilepsy in Neurodegenerative Diseases: Related Drugs and Molecular Pathways |
author |
Cano, Amanda |
author_facet |
Cano, Amanda Fonseca, Elena Ettcheto, Miren Sánchez-López, Elena de Rojas, Itziar Alonso-Lana, Silvia Morató, Xavier Souto, Eliana B. Toledo, Manuel Boada, Mercè Marquié, Marta Ruíz, Agustín |
author_role |
author |
author2 |
Fonseca, Elena Ettcheto, Miren Sánchez-López, Elena de Rojas, Itziar Alonso-Lana, Silvia Morató, Xavier Souto, Eliana B. Toledo, Manuel Boada, Mercè Marquié, Marta Ruíz, Agustín |
author2_role |
author author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Cano, Amanda Fonseca, Elena Ettcheto, Miren Sánchez-López, Elena de Rojas, Itziar Alonso-Lana, Silvia Morató, Xavier Souto, Eliana B. Toledo, Manuel Boada, Mercè Marquié, Marta Ruíz, Agustín |
dc.subject.por.fl_str_mv |
epilepsy neurodegenerative diseases Alzheimer’s disease Parkinson’s disease Huntington’s disease multiple sclerosis |
topic |
epilepsy neurodegenerative diseases Alzheimer’s disease Parkinson’s disease Huntington’s disease multiple sclerosis |
description |
Epilepsy is a chronic disease of the central nervous system characterized by an electrical imbalance in neurons. It is the second most prevalent neurological disease, with 50 million people affected around the world, and 30% of all epilepsies do not respond to available treatments. Currently, the main hypothesis about the molecular processes that trigger epileptic seizures and promote the neurotoxic effects that lead to cell death focuses on the exacerbation of the glutamate pathway and the massive influx of Ca2+ into neurons by different factors. However, other mechanisms have been proposed, and most of them have also been described in other neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, Huntington's disease, or multiple sclerosis. Interestingly, and mainly because of these common molecular links and the lack of effective treatments for these diseases, some antiseizure drugs have been investigated to evaluate their therapeutic potential in these pathologies. Therefore, in this review, we thoroughly investigate the common molecular pathways between epilepsy and the major neurodegenerative diseases, examine the incidence of epilepsy in these populations, and explore the use of current and innovative antiseizure drugs in the treatment of refractory epilepsy and other neurodegenerative diseases. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-10-18 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10316/105326 http://hdl.handle.net/10316/105326 https://doi.org/10.3390/ph14101057 |
url |
http://hdl.handle.net/10316/105326 https://doi.org/10.3390/ph14101057 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
1424-8247 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.publisher.none.fl_str_mv |
MDPI |
publisher.none.fl_str_mv |
MDPI |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799134109519314944 |